Analgesic nephropathy epidemiology and demographics: Difference between revisions

Jump to navigation Jump to search
Shankar Kumar (talk | contribs)
Created page with "__NOTOC__ {{Analgesic nephropathy}} Please help WikiDoc by adding content here. It's easy! Click here to learn about editing. ==References== {{ref..."
 
No edit summary
Line 2: Line 2:
{{Analgesic nephropathy}}
{{Analgesic nephropathy}}


Please help WikiDoc by adding content here. It's easy! Click [[Help:How_to_Edit_a_Page|here]] to learn about editing.
<br />
 
== Overview ==
There is insufficient evidence about the [[incidence]], [[prevalence]] and racial predilection of analgesic nephropathy. Most patients with analgesic nephropathy have been reported to be middle age or older with a history of chronic pain. There is insufficient evidence that suggests gender predilection in analgesic nephropathy. However, some studies suggest that analgesic nephropathy is more conman in females than males.
 
== Epidemiology and Demographics ==
 
=== Incidence ===
There is insufficient evidence about the [[incidence]] of analgesic nephropathy.
 
=== Prevalence ===
There is insufficient evidence about the [[prevalence]] of analgesic nephropathy.
 
=== Age ===
Most patients with analgesic nephropathy have been reported to be middle age or older with a history of chronic pain.  
 
=== Race ===
There is insufficient evidence that suggests racial predilection in analgesic nephropathy.
 
=== Gender ===
There is insufficient evidence that suggests gender predilection in analgesic nephropathy. However, some studies suggest that analgesic nephropathy is more conman in females than males.
 
==References==
==References==
{{reflist|2}}
{{reflist|2}}

Revision as of 06:25, 6 July 2020

Analgesic nephropathy Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Differentiating Analgesic nephropathy from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

CT

Treatment

Medical Therapy

Future or Investigational Therapies

Case Studies

Case #1

Analgesic nephropathy epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Analgesic nephropathy epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Analgesic nephropathy epidemiology and demographics

CDC on Analgesic nephropathy epidemiology and demographics

Analgesic nephropathy epidemiology and demographics in the news

Blogs on Analgesic nephropathy epidemiology and demographics

Directions to Hospitals Treating Analgesic nephropathy

Risk calculators and risk factors for Analgesic nephropathy epidemiology and demographics


Overview

There is insufficient evidence about the incidence, prevalence and racial predilection of analgesic nephropathy. Most patients with analgesic nephropathy have been reported to be middle age or older with a history of chronic pain. There is insufficient evidence that suggests gender predilection in analgesic nephropathy. However, some studies suggest that analgesic nephropathy is more conman in females than males.

Epidemiology and Demographics

Incidence

There is insufficient evidence about the incidence of analgesic nephropathy.

Prevalence

There is insufficient evidence about the prevalence of analgesic nephropathy.

Age

Most patients with analgesic nephropathy have been reported to be middle age or older with a history of chronic pain.  

Race

There is insufficient evidence that suggests racial predilection in analgesic nephropathy.

Gender

There is insufficient evidence that suggests gender predilection in analgesic nephropathy. However, some studies suggest that analgesic nephropathy is more conman in females than males.

References

Template:WH Template:WS